Skip to main content
. Author manuscript; available in PMC: 2018 Apr 18.
Published in final edited form as: Circulation. 2017 Feb 3;135(16):1494–1505. doi: 10.1161/CIRCULATIONAHA.116.025505

Table 5.

Association of hs-cTnT with incident HF

Categories of hs-cTnT (ng/L) Event Rate (/1000 p-yrs) Unadjusted Hazard Ratios Demographic adjusted + risk factors* + LVM & LVEF +NT-proBNP
  <LOD Reference Reference Reference Reference Reference
 3.0–4.25 0.8 (0.5, 1.3) 1.72
(0.82, 3.61)		 1.32
(0.62, 2.79)		 1.75
(0.85, 3.62)		 1.60
(0.78, 3.30)		 1.60
(0.77, 3.29)
 4.26–5.87 1.7 (1.0, 2.8) 2.61
(1.34, 5.10)		 1.75
(0.88, 3.47)		 1.74
(0.86, 3.50)		 1.53
(0.76, 3.10)		 1.57
(0.77, 3.17)
 5.88–8.80 2.1 (1.3, 3.2) 5.38
(2.96, 9.75)		 2.98
(1.60, 5.58)		 2.27
(1.18, 4.44)		 1.75
(0.90, 3.42)		 1.70
(0.87, 3.34)
 ≥8.81 11.7
(9.6, 14.3)		 14.13
(8.18, 24.4)		 6.45
(3.54, 11.79)		 5.59
(2.97, 10.68)		 3.47
(1.80, 6.68)		 2.93
(1.50, 5.67)
Test for trend <.001 <.001 <.001 <.001 <.001 .001
ln(hs-cTnT) N/A 3.12
(2.69, 3.63)		 2.59
(2.15, 3.13)		 2.35
(2.00, 2.78)		 1.88
(1.50, 2.35)		 1.55
(1.23, 1.95)
*

Risk factors: SBP, DBP, anti-hypertensive medications, diabetes (normal/DM), smoking, lipids, height, weight, and estimated GFR.

Cell values represent Hazard Ratios (95% CI).